Abstract:Age-related bone loss and disease strongly affect the quality of life of the elderly population. Cellular circadian rhythms have been reported to regulate bone aging, and micro RNAs (miRNAs) play crucial posttranscriptional regulatory roles in the peripheral clock network. Proliferation capability, osteogenic lineage commitment, senescence-associated secreted phenotype (SASP) and circadian oscillation of clock genes under osteogenic condition were assessed in bone marrow mesenchymal stromal cells (BMSCs) from young adult and aged adult mice. miRNAs targeting the core clock gene brain and muscle arntl-like protein 1 (Bmal1) were screened and verified in young and old BMSCs with RT-qPCR and Western Blot analysis. ChIP-seq and RNA-seq datasets were mined to define the downstream mechanism and gain- and loss-of-function genetic experiments were performed to confirm the hypothesis. To compare the therapeutic effect of these clock-engineered BMSCs, SASP and osteogenic capability of Bmal1-overexpressing and miR-142-3p-inhibited BMSCs were investigated in vitro and transplanted into bone defects and femur cavities of aged mice. Aged BMSCs displayed an abolished circadian rhythm, impaired self-renewal capability and decreased osteoblast differentiation. miR-142-3p was elevated with aging, which downregulated Bmal1 and diminished the osteogenic potential of BMSCs. In addition, Bmal1 inhibited YAP expression to promote BMSCs osteogenesis, which was independent from the activation of Hippo signaling pathway. Overexpression of Bmal1 or inhibition of miR-142-3p rescued the molecular temporal rhythm and osteoblast differentiation ex vivo. Cell-based circadian therapy showed improved bone formation and higher turnover levels in vivo. This study demonstrates that transcriptional and post-transcriptional level clock-modified BMSCs rescued circadian oscillation and age-related bone loss via miR-142-3p/Bmal1/YAP signaling axis. These data provide promising clinical prospects of circadian-mediated stromal cell-based therapy and bone tissue regeneration.

BMAL1 moonlighting as a gatekeeper for LINE1 repression and cellular senescence in primates

Emerging Insight Into the Role of Circadian Clock Gene BMAL1 in Cellular Senescence

METTL14 Regulates Intestine Cellular Senescence Through M6a Modification of Lamin B Receptor

miR-155-5p/Bmal1 Modulates the Senescence and Osteogenic Differentiation of Mouse BMSCs through the Hippo Signaling Pathway

Circadian clock protein BMAL1 regulates cellular senescence in vivo

BMAL1-TTK-H2Bub1 Loop Deficiency Contributes to Impaired BM-MSC-mediated Bone Formation in Senile Osteoporosis

BMAL1 represses transposable elements independently of CLOCK in pluripotent cells

Over-expression of circadian clock gene Bmal1 affects proliferation and the canonical Wnt pathway in NIH-3T3 cells.

Bmal1- and Per2-mediated regulation of the osteogenic differentiation and proliferation of mouse bone marrow mesenchymal stem cells by modulating the Wnt/β-catenin pathway

Timing of expression of the core clock gene Bmal1 influences its effects on aging and survival

Single cell RNA sequencing unravels mechanisms underlying senescence-like phenotypes of Alveolar Macrophages

Bmal1- and Per2-mediated Regulation of the Osteogenic Differentiation and Proliferation of Mouse BMSCs by Modulating the Wnt/β-catenin Pathway

M6a Epitranscriptomic Regulation of Tissue Homeostasis During Primate Aging

Stabilization of heterochromatin by CLOCK promotes stem cell rejuvenation and cartilage regeneration

The E3 Ubiquitin Ligase STUB1 Attenuates Cell Senescence by Promoting the Ubiquitination and Degradation of the Core Circadian Regulator BMAL1

Downregulation of MLF1 safeguards cardiomyocytes against senescence-associated chromatin opening

Circadian Clock Proteins Regulate Neuronal Redox Homeostasis and Neurodegeneration.

Clock-modified Mesenchymal Stromal Cells Therapy Rescues Molecular Circadian Oscillation and Age-Related Bone Loss Via Mir142-3P/bmal1/yap Signaling Axis

BMAL1 regulates osteoblast differentiation through mTOR/GSK3/-catenin pathway

BMAL1 knockout macaque monkeys display reduced sleep and psychiatric disorders

Targeted Bmal1 restoration in muscle prolongs lifespan with systemic health effects in aging model